Skip to main content
FinSpry Logo
FinSpry
DGX logo
DGX
(NYSE)
Quest Diagnostics Incorporated
$193.75-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Quest Diagnostics Incorporated (DGX) Stock Price & Financial Analysis

Quest Diagnostics Incorporated Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$187.25 - $191.16
52-Week High$213.50
52-Week Low$164.65
Open$187.64
Volume859.85K
Average Volume (3M)986.58K
Market Cap20.90B
Shares Outstanding112.00M
P/E Ratio (TTM)20.41
Forward P/E18.27
Price to Sales (P/S)1.85
Price to Book (P/B)2.84
EV/EBITDA11.74
Revenue (TTM)11.28B
Net Income (TTM)1.02B
Free Cash Flow (TTM)1.33B
EPS (TTM)$9.10
Profit Margin9.08%
Operating Margin14.31%
Return on Equity (ROE)13.90%
Debt to Equity0.77
50-Day MA$196.48
200-Day MA$187.11
52-Week Change7.91%
Annual Dividend$3.26
Dividend Yield1.72%
Payout Ratio35.82%
Last Dividend Ex-DateApr 6, 2026

Frequently Asked Questions About Quest Diagnostics Incorporated

What is the current stock price for DGX?

As of the latest trading session, DGX stock trades at $189.84. The 52-week range is $164.65–$213.50, with a day range of $187.25–$191.16.

What is the P/E ratio for DGX?

Quest Diagnostics Incorporated's trailing P/E ratio is 20.4, meaning investors pay $20.4 for every $1 of annual earnings. The forward P/E is 18.3, reflecting analyst expectations for future earnings. Quest Diagnostics Incorporated operates in the Healthcare sector.

Does DGX pay dividends?

Yes, Quest Diagnostics Incorporated pays a 1.72% annual dividend yield ($3.26 per share). The payout ratio is 35.8%. The last ex-dividend date was 2026-04-06.

What do analysts recommend for DGX?

Based on 5 analysts, the consensus for DGX is Hold. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of DGX?

Quest Diagnostics Incorporated's market capitalization is $21.26B, classifying it as a large-cap company. Quest Diagnostics Incorporated operates in the Healthcare sector within the Diagnostics & Research industry.